CIK 0001053691 · Non-accelerated filer<br>Smaller reporting company
CervoMed Inc.
Sign in to watch- Ticker
- CRVO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 300645032
- Phone
- (617) 744-4400
- Business address
- 20 PARK PLAZA, SUITE 424, BOSTON, MA, 02116
- Former names
- Diffusion Pharmaceuticals Inc., RestorGenex Corp, Stratus Media Group, Inc, FERIS INTERNATIONAL, INC., TITAN MOTORCYCLE CO OF AMERICA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2014-06-06 | BARER SOL J Chairman of the Board | Grant or award · Warrant | +95,170 | 95,170 | ||
| 2014-06-03 | SHERRIS DAVID CSO & President of Division | Grant or award · Stock Option (right to buy) | +115,193 | 115,193 | ||
| 2014-06-03 | Abolin Craig VP of Research & Dev - Subsid. | Grant or award · Stock Option (right to buy) | +57,596 | 57,596 | ||
| 2014-06-03 | Schwartz Yael President of Subsidiaries | Grant or award · Stock Option (right to buy) | +115,193 | 115,193 | ||
| 2014-05-27 | DONENBERG PHILIP B Chief Financial Officer | Grant or award · Stock Option (right to buy) | +250,000 | 250,000 | ||
| 2014-03-05 | SIMES STEPHEN M Chief Executive Officer | Grant or award · Stock Option (right to buy) | +50,000,000 | 50,000,000 | ||
| 2014-02-05 | Bright Rex Director | Grant or award · Stock Option (right to buy) | +1,650,000 | 1,650,000 | ||
| 2014-01-07 | BLECH ISAAC Director | Grant or award · Stock Option (right to buy) | +17,441 | 17,441 | ||
| 2013-05-29 | BLECH ISAAC 10% owner | Conversion | +8,333,333 | $0.06 | $500K | 26,666,667 |
| 2013-05-29 | BLECH ISAAC 10% owner | Option exercise | +3,571,429 | 30,238,096 | ||
| 2013-05-29 | BLECH ISAAC 10% owner | Conversion | +108,333,333 | $0.06 | $6.5M | 138,571,429 |
| 2013-05-29 | BLECH ISAAC 10% owner | Option exercise | +46,428,571 | 185,000,000 | ||
| 2013-05-29 | BLECH ISAAC 10% owner | Conversion · Series E Preferred Stock, par value $0.001 per share | −500 | 0 | ||
| 2013-05-29 | BLECH ISAAC 10% owner | Option exercise · Warrants (right to buy) | −1,250,000 | 0 | ||
| 2013-05-29 | BLECH ISAAC 10% owner | Option exercise · Warrants (right to buy) | −625,000 | 0 | ||
| 2013-05-29 | BLECH ISAAC 10% owner | Conversion · Series E Preferred Stock, par value $0.001 per share | −6,500 | 0 | ||
| 2013-05-29 | BLECH ISAAC 10% owner | Option exercise · Warrants (right to buy) | −16,250,000 | 0 | ||
| 2013-05-29 | BLECH ISAAC 10% owner | Option exercise · Warrants (right to buy) | −8,125,000 | 0 | ||
| 2013-05-02 | BLECH ISAAC 10% owner | Purchase | +18,333,334 | $0.06 | $1.1M | 18,333,334 |
| 2010-04-14 | Feller Paul Chief Executive Officer | Other acquisition | +1,735,505 | 25,812,591 |
Page 16 of 17 · 321 trades